Stephen David Prior

Insider Reports History

Location: C/O An2 Therapeutics, Inc., 1800 El Camino Real, Suite D, Menlo Park, CA
Signature: /s/ Lucy Day, Attorney-in-Fact for Stephen David Prior
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen David Prior:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
AN2 Therapeutics, Inc.	Chief Strategy Officer	Common Stock	61.3K	$82.2K	$1.34	Feb 26, 2025	Direct
AN2 Therapeutics, Inc.	Chief Strategy Officer	Stock Option (right to buy)	56K			Feb 26, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Stephen David Prior

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ANTX	AN2 Therapeutics, Inc.	Feb 26, 2025	2	$0	4	Feb 28, 2025	Chief Strategy Officer
ANTX	AN2 Therapeutics, Inc.	Jan 3, 2025	1	-$2.72K	4	Jan 7, 2025	Chief Strategy Officer
ANTX	AN2 Therapeutics, Inc.	Nov 4, 2024	2	$0	4	Nov 5, 2024	Chief Strategy Officer
ANTX	AN2 Therapeutics, Inc.	Nov 4, 2024	0	$0	3	Nov 5, 2024	Chief Strategy Officer